Pricing Log in Create free account

Editas Medicine, Inc. (EDIT) vs Prothena Corporation plc (PRTA)

Editas Medicine, Inc. and Prothena Corporation plc are both Biotechnology companies. Editas Medicine, Inc. and Prothena Corporation plc are of similar size ($405.1M and $391.6M). Prothena Corporation plc grew revenue faster over the last twelve months: 347.4% against 20.8%. Prothena Corporation plc has the higher net margin (−45.4% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Prothena Corporation plc leads on 12 and Editas Medicine, Inc. on 3.

Valuation

Metric EDIT PRTA Biotechnology median
P/E n/m n/m 10.60
P/S 6.52 7.76 9.40
P/B 2.91 1.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.71 2.62 9.02
Earnings yield (29.18%) (5.90%) (32.88%)
Free cash flow yield (39.23%) (7.86%) (23.13%)

Profitability

Metric EDIT PRTA Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (161.39%) (64.64%) 0.00%
Net margin (157.32%) (45.43%) 0.00%
Free cash flow margin (255.88%) (61.03%) 0.00%
Return on equity (118.82%) (8.50%) (51.96%)
Return on assets (33.02%) (7.53%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDIT PRTA Biotechnology median
Revenue growth (TTM) 20.83% 347.44% 6.76%
EPS growth (last fiscal year) 37.50% (99.56%) 29.88%
Revenue growth, 5-year CAGR (14.89%) 62.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 23.95 4.97
Net debt to EBITDA 0.94 1.46 1.01

Dividend

Metric EDIT PRTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EDIT PRTA Biotechnology median
Market cap 391.63m 405.05m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack